top of page
Japan Biotech Asset Licensing J-Biosciences

Our Team

Our Veteran Muti-cultural Team

yuko terasawa J-Bioscienses

Yuko Terasawa Ph.D.
Founding Partner

  • Yuko has 20+ years of business development and drug discovery experience

  • Extensive global network in biotech/pharma

  • Established and managed over 20 strategic partnerships to accelerate development

  • Experienced in every stage of therapeutic development including research, lead discovery, preclinical and clinical development 

  • B.S., UC Davis; Ph.D., UC Berkeley

Jerrod Stelli J-Bioscienses

Jerrod Stelli
Founding Partner

  • Jerry has 30+ years experience in capital markets, investment banking and alternative investment management in Tokyo, Hong Kong, New York and London

  • CEO of Matrix Japan K.K., a Japanese FSA securities company and cross border corporate advisory firm focused on Japanese & Asian financial and strategic investors’ overseas businesses

  • Experience in private equity, M&A and credit investments in healthcare: biotech, services and devices

  • BA, Columbia University; Stanford University, Graduate School of Business

Rob Claar J-Bioscienses

Robert E. Claar
Founding Partner

  • Rob creates new businesses in Japan that address the unmet needs of patients, doctors, innovators, and authorities

  • Co-founder & CEO, HekaBio K.K.

  • Founder of one of Japan’s first medical market intelligence firms (Junicon) and a CRO leading Japan in new category medical device approvals and reimbursement (Vorpal Technologies)

  • Three decades of focus on Japan’s healthcare ecosystem

  • Regulatory knowhow and strong Key Opinion Leader doctor networks

  • Worldwide trust network with leading innovators in pharmaceuticals and MedTech

  • BA, Yale University

bottom of page